1-1 of 1
Marites Lang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combination of Sorafenib, Idarubicin, and Cytarabine Has a High Response Rate in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Younger Than 65 Years

Free
Farhad Ravandi, MBBS, Jorge Cortes, MD, Stefan Faderl, MD, Guillermo Garcia-Manero, MD, Susan O’Brien, M.D., Gautam Borthakur, MD, Sherry Pierce, BSN, Mark Brandt, BS, Marites Lang, RN, Weiguo Zhang, MD, PhD, Rajyalakshmi Luthra, PhD, Dan Jones, MD, PhD, Mark J. Levis, MD, PhD, Marina Konopleva, MD, PhD, Michael Andreeff, MD, PhD, Hagop M Kantarjian
Journal: Blood
Blood (2008) 112 (11): 768.
https://doi.org/10.1182/blood.V112.11.768.768
Published: 2008